Switzerland Agrees to Shift Key Manufacturing Sectors to U.S. in Tariff Deal
Switzerland will relocate significant pharmaceutical, metals, and rail production to the United States under a newly negotiated trade agreement. The resolution follows months of strained talks initiated in April after the TRUMP administration threatened punitive tariffs following collapsed preliminary discussions.
The accord aligns Swiss tariffs with EU rates, defusing tensions that had pressured Switzerland's trade-reliant economy. U.S. Trade Representative Jamieson Greer confirmed the breakthrough, noting Swiss manufacturers committed to establishing U.S. production facilities for pharmaceuticals, Gold smelting, and railway equipment.
Both governments will publish detailed terms later today, with Swiss officials scheduled to outline long-term trade balancing measures during a 4 p.m. announcement. The Core concession sees Switzerland producing high-export commodities on American soil in exchange for reduced tariffs.
